Bio-Path Holdings, Inc. to Present at the 12th Annual Biotechnology Industry Organization (BIO) Investor Forum
Published: Oct 01, 2013
Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive Officer, will present a company overview at the 12th Annual BIO Investor Forum Conference in San Francisco on Tuesday, October 8, 2013 at 11:00 a.m. Pacific Time (2:00 p.m. Eastern Time).
Help employers find you! Check out all the jobs and post your resume.